Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 11/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.37 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gentiopicroside SCHEMBL31387950 | 0.94 | STAT3 (0.58) | STAT3PTPN1MAPTMEN1KMT2A | |
| Gentiopicroside SCHEMBL154304 | 0.94 | STAT3 (0.58) | STAT3PTPN1MAPTMEN1KMT2A | |
| SCHEMBL29655354 | 0.90 | STAT3 (0.54) | STAT3PTPN1MAPTMEN1KMT2A | |
| SCHEMBL28586772 | 0.80 | STAT3 (0.48) | STAT3PTPN1MAPTMEN1KMT2A | |
| SCHEMBL29655381 | 0.76 | HSP90AA1 (0.48) | STAT3PTPN1CA12CA1CA2 | |
| SCHEMBL29949817 | 0.71 | GAA (0.61) | PTPN1MEN1KMT2ACDK1CCNB1 | |
| SCHEMBL29391780 | 0.70 | STAT3 (0.38) | STAT3PTPN1MAPTMEN1KMT2A | |
| Sweroside SCHEMBL307117 | 0.69 | STAT3 (1.00) | STAT3PTPN1MAPTMEN1KMT2A | |
| Sweroside SCHEMBL14278967 | 0.69 | STAT3 (1.00) | STAT3PTPN1MAPTMEN1KMT2A | |
| SCHEMBL28267368 | 0.67 | STAT3 (0.72) | STAT3PTPN1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116858971-A | Construction method of chrysanthemum and poria cocos compound fingerprint and application thereof | 北京中医药大学 | 2023-10-10 | — | — | CN | claimed |
| CN-116399977-A | Method for simultaneously determining multiple components in liver-strengthening capsules based on liquid chromatography-mass spectrometry technology and application | 石家庄东方药业股份有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-116858971-B | Construction method of chrysanthemum and poria cocos compound fingerprint and application thereof | 北京中医药大学 | 2025-12-05 | — | — | CN | disclosed |
| CN-117470982-A | Method for researching pharmacokinetics and tissue distribution characteristics of gentian dragon capsule in vivo | 西安正大制药有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-116858971-A | Construction method of chrysanthemum and poria cocos compound fingerprint and application thereof | 北京中医药大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116858971-A | Construction method of chrysanthemum and poria cocos compound fingerprint and application thereof | 北京中医药大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116399977-A | Method for simultaneously determining multiple components in liver-strengthening capsules based on liquid chromatography-mass spectrometry technology and application | 石家庄东方药业股份有限公司 | 2023-07-07 | — | — | CN | disclosed |